Identification of somatically acquired BRCA1/2 mutations by cfDNA analysis in patients with metastatic breast cance

PURPOSE: Plasma genotyping may identify mutations in potentially “actionable” cancer genes, such as BRCA1/2, but their clinical significance is not well defined. We evaluated the characteristics of somatically acquired BRCA1/2 mutations in patients with MBC. METHODS: Patients with MBC undergoing rou...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Cancer Res
Main Authors: Vidula, Neelima, Dubash, Taronish, Lawrence, Michael S., Simoneau, Antoine, Niemierko, Andrzej, Blouch, Erica, Nagy, Becky, Roh, Whijae, Chirn, Brian, Reeves, Brittany A., Malvarosa, Giuliana, Lennerz, Jochen, Isakoff, Steven J., Juric, Dejan, Micalizzi, Douglas, Wander, Seth, Spring, Laura, Moy, Beverly, Shannon, Kristen, Younger, Jerry, Lanman, Richard, Toner, Mehmet, Iafrate, A. John, Getz, Gad, Zou, Lee, Ellisen, Leif W., Maheswaran, Shyamala, Haber, Daniel A., Bardia, Aditya
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7501190/
https://ncbi.nlm.nih.gov/pubmed/32571788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-0638
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki